2,115 press releases in English indexed under biotech & pharma.
LEXINGTON, Mass., October 22, 2026--Agenus Inc. ("Agenus") (Nasdaq: AGEN ), a leader in immuno-oncology innovation, today announced that the Company will release its third quarter 2026 financial results before the market opens on Thursday, November 5, 2026. The earnings release will review Agenus' rec
LOS ANGELES, October 22, 2026--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, November 5, 2026, following the release of its third quarter 2026 financial results. The call may be accessed by dialing 1-877-709-8
AUSTIN, Texas, October 22, 2026--Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced that the Compensation Committee of Faeth's Board of Directors granted three new employees options to purchase an aggregate of 17,000 shares of the Company's common stock in connection with their employment (collecti
Suit alleges Unicycive Therapeutics, Inc. failed to disclose key facts to investors from December 29, 2025 through June 29, 2026; lead plaintiff deadline is November 2, 2026 BENSALEM TOWNSHIP, Pa., Oct. 22, 2026 -- The Law Offices of Howard G. Smith today reported that a...
CARLSBAD, Calif., October 22, 2026--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the company was named the top employer to work for by Science in its annual Top Employers survey of the biotech and pharmaceutical industries. Rising from #2 last year to #1, Ionis was recognized for it
Anatomy segmentation and three-dimensional skeletal visualization arrive with this clearance; an injury detection module for clinical decision support is in development on the platform roadmap CHARLOTTESVILLE, Va., Oct. 22, 2026 -- RIVANNA®, developer of AI-enabled clinical...
Founded by leaders from OpenAI, Terremoto Biosciences, Meta, Devoted Health, and the White House, Warp is using AI and robotics to help biotech and pharma discover new medicines faster in the U.S. The company is backed by Lightspeed, IVP, Mayfield, Lux, Premji Invest, and Menlo Ventures, among others SAN FRANCISCO, Octobe
DURHAM, N.C., October 22, 2026--Grid Therapeutics , a clinical-stage biotechnology company committed to developing better and safer human-derived therapeutic antibodies for cancer, today announced that new data on its lead clinical asset, GT103, will be presented at the 2026 European Society for Medic
CLICHY, France, October 22, 2026--CorWave SA, a clinical-stage medical technology company pioneering innovative cardiac assist devices, announces the completion of enrollment in its feasibility study of the CorWave Left Ventricular Assist System (LVAS). The company also presented the first clinical da
Marking 15 years of specialized phototherapy, patient-centered care, and expanding access to drug-free treatment for psoriasis, vitiligo, eczema, and other chronic skin conditions. LOS ANGELES and ORANGE COUNTY, Calif., Oct. 22, 2026 -- Array Skin Therapy, a provider of...
OPM-201: secured funding from the Michael J. Fox Foundation to support the development of the LARKIN program in Parkinson's disease OPM-101: continued preparation for the REVERT Phase 1b/2a clinical trial in advanced melanoma and partnership discussions regarding chronic inflammatory bowel diseases Significant reduction i
Independent Data Monitoring Committee recommends ASPIRE continue without modification; no safety concerns identified Fully enrolled 378-patient trial advances toward 52-week readout STOCKHOLM, SE AND CAMBRIDGE, MA / October 22, 2026 / Vicore Pharma Holding AB (Nasdaq Stockholm:VICO)(Nasdaq US:VCRE), a bi